Company: QTIWW
Filing Date: 2025-12-31
Form Type: 424B3
Source: 0001628280-25-059235
Chunk: 152

Company: QT IMAGING HOLDINGS, INC.
Filing Date: 2025-12-31
Form: 424B3
Chunk 152
---
 the earlier of (i) the date on which we consummated the Business Combination with GigCapital5, Inc.; (ii) the date we wind up; or (iii) December 31, 2023. On March 4, 2024, the Working Capital Note was agreed to be amended and subordinated pursuant to and in accordance with the terms of the Business Combination Agreement. Effective on the closing of the Business Combination, the Working Capital Note cannot be repaid prior to the repayment or conversion of the Yorkville Note issued to Yorkville. In connection with the issuance of the Lynrock Lake Term Loan, on February 26, 2025, the maturity date on the Working Capital Note was extended to October 1, 2027. As of September 30, 2025 and December 31, 2024, the outstanding balance of the Working Capital Note was $705,000.

<div align='center'>92</div>

#### Cash Flows
The following table provides information regarding our cash flows for the periods presented:

|                                                               |     | Nine Months Ended 
 September 30,     |       2025 |     |   |       2024 |
|:--------------------------------------------------------------|:----|:------------------|-----------:|:----|:--|-----------:|
| Net cash used in operating activities                         |     | $                 | -5,857,572 |     | $ | -8,806,402 |
| Net cash used in investing activities                         |     |                   |    -46,818 |     |   |    -34,590 |
| Net cash provided by financing activities                     |     |                   |  6,447,686 |     |   | 10,220,475 |
| Net increase in cash and restricted cash and cash equivalents |     | $                 |    543,296 |     | $ |  1,379,483 |

#### Net Cash Used In Operating Activities
Net cash used in operating activities was $5,857,572 for the nine months ended September 30, 2025 as compared to $8,806,402 for the nine months ended September 30, 2024. The primary use of our cash was to fund research and development and general and administrative expenses. Net cash used for the nine months ended September 30, 2025 consisted of a net loss of $19,694,921, adjusted for non-cash expenses primarily including depreciation and amortization of $115,